chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, fever, chills, frequent urination, racing heart rate, excessive sweating.  Symptoms resolved on their own.
Seen in ED on 10/2/2006 with fever (102F), vomiting, gagging, stuffy nose, wheezy. Has past hx of elevated blood lead level of 11 on 6/20/2006
shortness of breath; rash around his waist, on his hands and back; pulse dropped; This spontaneous case was reported by a consumer and describes the occurrence of PULSE ABNORMAL (pulse dropped), DYSPNOEA (shortness of breath) and RASH (rash around his waist, on his hands and back) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PULSE ABNORMAL (pulse dropped) and RASH (rash around his waist, on his hands and back). On an unknown date, the patient experienced DYSPNOEA (shortness of breath). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at an unspecified dose and frequency; LISINOPRIL ongoing since an unknown date at an unspecified dose and frequency; HYDROCHLOROTHIAZIDE ongoing since an unknown date at an unspecified dose and frequency; METFORMIN ongoing since an unknown date at an unspecified dose and frequency; ACETYLSALICYLIC ACID (BABY ASPIRIN) ongoing since an unknown date at an unspecified dose and frequency; EMPAGLIFLOZIN (JARDIANCE) ongoing since an unknown date at an unspecified dose and frequency; INSULIN GLARGINE (TOUJEO SOLOSTAR) ongoing since an unknown date at an unspecified dose and frequency and NYSTATIN (STATIN [NYSTATIN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PULSE ABNORMAL (pulse dropped), DYSPNOEA (shortness of breath) and RASH (rash around his waist, on his hands and back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter.
12/16 - 11AM VACCINE RECEIVED 12/17- 6AM HANDS SWELLING SEEN 12/18 - 6AM EYELIDS AND CHEEKS SWELLING SEEN
chills,T 101.4, myalgia,arthalgia (mainly knee caps), whoozy feeling, fatigue, HA
This is a 66y.o. male . He presented with manic features. He had been spending excessive amounts of money and had not been sleeping. While patient was with us he became positive for COVID-19 hence was discharged to a medical unit. Please refer to previous admission note for details.
Dysmenorrhea/Amenorrhea   Dysmenorrhea starting June 13 lasting for a period of 14 days, followed by amenorrhea  starting June 27-September 19th. This ended with a brief period of spotting from the 19th through the 24th. Early menopause was given as a differential diagnosis from OB/GYN.
Skin Lesion - Information has been received from a physician concerning an approximately 27 year old female patient who was vaccinated with varicella virus vaccine live.  Three years post-vaccination, the patient developed approximately 15-20 lesions.  The patient sought unspecified medical attention.  Additonal information has been requested.
Red, blistering, itching rash on arm at site of injection where Zostavax was given five days previously.  Diagnosed as cellulitis.  Presently taking Keflex for seven days.
painful red bump 0.8 cm in diameter erupted in her right arm; Itchy, painful red bump 0.8 cm in diameter erupted in her right arm; Itchy, painful red bump 0.8 cm in diameter erupted in her right arm; Itchy, painful red bump 0.8 cm in diameter erupted in her right arm; This case was reported by a pharmacist via call center representative and described the occurrence of local swelling in a 73-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2KK23, expiry date unknown) for prophylaxis.   On 23rd September 2020, the patient received Boostrix. On 23rd September 2020, less than a day after receiving Boostrix, the patient experienced local swelling, pruritus, pain in arm and erythema. On an unknown date, the outcome of the local swelling, pruritus and pain in arm were unknown and the outcome of the erythema was not recovered/not resolved.   It was unknown if the reporter considered the local swelling, pruritus, pain in arm and erythema to be related to Boostrix.  Additional details were provided as follows: The patient received Boostrix and experienced itchy, painful red bump 0.8 cm in diameter erupted on her arm (unknown if bump is at exact site of injection, it is the right arm, same as injected arm) which was not recovered till the time of reporting. When palpitated it doesn't feel like there's water or liquid inside. The reporter did not consented to follow up. No further information was available.
On 11/15 he had nasal congestion and sore throat, cough. 11/16 we went to the doctor, at first the doctor though it was allergies and recommend he take an allergy medicine. I had Hydroxyzine 12.5ml at home and gave him that. They called later that night and said he was positive 11/23 He started to feel better. 11/24 he started to get a rotten smell all time when he breathes through his nose.
Difficulty breathing; heaviness in chest; bad joint pain; exhaustion; cough; pneumonia.
t/c from client 03/14/2005 stating "2 days after my 2nd Hep B shot I got blisters in my throat and my face broke out. I called the doctor he said to just watch and see. The blisters were gone by sunday but my face still has places where you can tell I had something"
No adverse effects; The patient was vaccinated with improperly stored VARIVAX; This spontaneous report was received from a nurse and refers to a 3 unspecified patients of unknown age and gender. The patients' medical history, concomitant medications, drug reactions or allergies were not reported.  On 07-AUG-2019, the patients were vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose, lot # R031626, expiration date: 01-NOV-2020 (strength, route of administration and anatomical location were not provided) for prophylaxis. Temperature excursion was 11. Fahrenheit (F) during a time frame of 1 hour and 36 minutes which was recorded by a data logger. No previous temperature excursions were involved. No adverse effects were reported.   Follow up information was received form the nurse concerning a 3 years old female patient on 15-AUG-2019.   Patient demographics were updated.   On 07-AUG-2019, the patient was vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck)(VARIVAX), subcutaneously, lot number R031626, expiration date: 01-NOV-2020 in the right arm (strength was not provided) for prophylaxis.   The reporter stated that three doses of varicella virus vaccine live (oka/merck)(VARIVAX) were accidentally administered before realized the digital data logger noted an out of range temperature. Upon realized the out of range temperature measures were taken to address it staff was educated on excursion process and ways to prevent this from happening in the future.  This is one of three cases received by the same reporter.; Sender's Comments:  US-009507513-1908USA006567: US-009507513-1908USA006568:
Fever of 102.5 about 5 hrs after shots were given; irritable.
Pt felt "faint" pale skin and very tired and weak lightheadness when standing x 36 hours
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2015, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2016, the patient was treated by health professional for the onset of a vesicular rash which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Large, swollen, hot, itchy red reaction at injection site and numbness in the face.  Dr. advised to take Benadryl, which did help with the discomfort at the injection site, but no the numbness.  The next day the numbness had spread to also include the left arm, hand, and foot.  Dr. saw me on March 10th and referred me to a neurologist.  Upon examination by a neurologist on March 22,  he said that I had hyper reaction to stimuli to the nervous system.  Also experiencing a worsening of previously existing vertigo.  He sent me for MRI of the head and neck on March 23.  The MRIs showed insignificant abnormalities that did not seem related to the numbness, thus it is likely caused by the vaccine.
an expired dose of Daptacel was given, NO AE; Initial information received on 25-Oct-2019 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 19 months old female patient received a 0.5 ml dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE (lot: C5307AA, expiry date: 23-Oct-2019) via intramuscular route in the left thigh on 25-Oct-2019.  The patient past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due expired product administered. It was reported that an expired dose of Daptacel was given.  At the time of reporting, the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error
ACUTE NON ST ELEVATION MI 2/12/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
This spontaneous report as received from a physician refers to a 12 year old patient (gender unknown). On approximately 11-AUG-2014 (also reported as this past Monday) the patient was vaccinated with GARDASIL standard dose, first shot in series, lot # K001631 (route of administration not reported). On the same date, the patient also received MENACTRA (manufacturer unknown). On 11-AUG-2014, the patient experienced muscle spasms, tightness in chest, swollen tongue and itchy dace after receiving GARDASIL. The physician recommended the patient not to receive any further doses in the series. The patient was given treatment with BENADRYL (therapy route unspecified). The adverse events improved. The patients present status was reported as recovered (date unspecified). It was reported that the patient sought medical attention but unspecified how. The causality for the event was unknown. No product quality issue (PQC) had been reported. Additional information has been requested.
3/20 I noticed a scratchy throat and malaise. 3/21 tested positive with at home COVID-19 test. I developed a severe headache with loss of taste and smell, and a terrible cough. 3/22 Televisit with doctor who prescribed PAXLOVID and recommended DELSYM cough syrup. 3/24 I felt better, with taste and smell returning. Felt much better by 3/27 with cough lingering for about a month longer. Fatigue and lethargy linger to time of reporting.
Broke out in rash over his back. His knees swale up that he could not bend them.
Patient experienced razor-burn like rash all over her body, except the face. She has been drinking lots of water to help with the symptoms but no help. Patient also experiencing burning sensation in throat area. She called her doctor to get medication to help treat symptoms and tried Prednisone 10mg three times per day for 5 days, but is still experiencing adverse effect.
fever; headache; sore arm; felt a little sick; This is a spontaneous report from a contactable consumer via Pfizer sales representative. This consumer reported for a patient that.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2 SINGLE, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1 SINGLE for covid-19 immunization. The patient medical history and  concomitant medications were not reported. On an unspecified date the patient experienced fever, headache, sore arm, and felt a little sick. The reporter was unclear if the patient had the Pfizer or Moderna COVID-19 vaccine.  No further information expected.
PT DEVELOPED A 2-3 INCH CIRCULAR RASH WITH A BLISTER.
Swelling and redness of right upper arm from deltoid area to elbow with edema of forearm and hand began one day post vax. Pt seen two days post vax at height of erythema/edema. Pt treated with Tylenol, Benadryl and topical HC.
Induration, swelling, redness and warmth of the location of vaccine injection in left arm after the vaccination applied in 01/21/2003. Right now I show all of these symptom to supervisor.
Fever of 104-105 for 10 days. She also had bronchospasms, sore throat, diarrhea, vomiting, loss of appetite, hallucinations and cough, all lasting for 2 weeks.
My symptoms began in January, and I had sinus congestion and drainage.  I did not have fever.  I had some fatigue and body aches.  I tested positive for 6 days.  On the 2nd day I began taking an antiviral.  I was then negative for 8 days and then I had a rebound positive test for another 6 days.  The symptoms were the same and lasted for about another 6 days.
given only the liquid component; given only the liquid component; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA584A, expiry date 30th April 2023) for prophylaxis.   On 22nd September 2021, the patient received Menveo. On 22nd September 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The physician's assistant reported that, the patient was given only the liquid component without the lyophilized component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  No symptoms reported. The reporter consented to follow up.
Onset of S&S 3-4 hrs post jab.  Develop profound fatigue,  severe chills,  joint and bone pain,  profound weakness,  headache.  Considered going to ER,  thought I might die.  Took Motrin (I believe) with some relief.  S&S gradually subsided over next 24-36 hrs
Systemic: Seizure-Severe, Systemic: Shakiness-Severe, Additional Details: PT REPORTED HAVING SEIZURES FROM HEAD TO TOE  UPON ARRIVING AT HOME AFTER RECEIVING FLUZONE HIGH DOSE VACCINE FROM PHARMACY AND PT HAD TO SEEK EMERGENCY CARE IN THE HOSPITAL
excruciating headache for 13 hrs,  cold chills for 2 days, hot flashes that made me feel like my insides were melting for 3 days, body aches; hips and pelvis area. As well as legs and feet cramping.  Loss of concentration. Light headedness. No appetite for 2.5 days.
Headache, extremely sore eyes , slight cough, confusion, fatigue and chest pain.
This spontaneous report was received from a registered pharmacist concerning an approximately a 62 year old female patient with no pertinent medical history and no drug reactions or allergies. On 04-NOV-2013, the patient was vaccinated with 0.65 milliliter (ml) of ZOSTAVAX (lot number and expiry date were reported as J004311 and 12-JUL-2014 respectively), subcutaneously. There were not concomitant medications. On 06-NOV-2013 the patient reported that she experienced redness at injection site with some swelling. The patient sought medical attention (consulted pharmacist). The patient asked what to do for treatment and was not treated for reaction till the time of report. The patient was not recovered from redness at injection site with some swelling at the time of report. The relatedness for redness at injection site with some swelling was unknown for ZOSTAVAX. Additional information has been requested.
Patient's vaccine site is red and swollen and nodular. It is inflamed and has been so since the vaccine was administered 1/18/16. Patient is monitoring reaction.
Initial: nausea, dizziness, throat swelling, palpitation. Seen in ED, hypotensive, received epinephrine, methlprdnisolone, and fluids with resolution of muffled hearing and throat tightness. Then complained of numbness of tongue, burning of dorsum of tongue, dizziness, dysphagia for approx 3 weeks, then with resolution.
Body aches; could not do ADL's. Coughing, sneezing, no energy, in bed for 4 months, up for two hours then rest of day in bed. Puneal weight-not active.
pt recvd vax & exp nausea the next morning which resolved p/eating; treatment: none; pt recvd 2nd dose of vax 14JUN93 8AM w/no complaints;
Information has been received from a physician concerning a patient's mother. The patient's mother had a history of varicella at 12 years old. On 02/09/1998, the patient was vaccinated with varicella virus vaccine live, subcutaneously in the left thigh and on 02/23/2001 presented in the physician's office with chicken pox. The physician reported that the patient's mother who had a chicken pox when she was 12 years old, had a chicken pox from her child two weeks later. The physician also reported on the daughter who experienced events following vaccination with varicella virus live. No further information available.
The patient called on 9/14/21 to report redness that developed in the arm that she received her flu shot on 9/12/21. The size of the red area was about 5 inches long. She said that applying ice helped, and instructed patient to continue ice application along with taking diphenhydramine every 4 to 6 hours to see if redness resolves. Will follow up with patient in a few days when I am back at work.
pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (pain in arm). At the time of the report, PAIN IN EXTREMITY (pain in arm) outcome was unknown. Not Provided          This case was linked to MOD-2021-064163.; Sender's Comments:  MOD-2021-064163:first dose
myasthenia gravis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYASTHENIA GRAVIS (medically significant), outcome "unknown". Patient just got diagnosed with myasthenia gravis from having Covid shots. Reporter would like to know how concerned should they be about taking more Covid shots.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Right after injection I got very hot and dizzy. I could not stand up. Health Dept had to lay me down. My blood pressure was very low, I was pale in color. After about 30 to 45 minutes I got in car and went home. Where another 2 hours before I was able to get out of bed.
Palm size res splotch o left arm lasting 4 days. Fever of 100 degrees lasting 4 days (5/5-5/8). General tiredness, joint pain. (Possible flare of Rheumatoid arthritis)
Pt complained really sore arm, could not sleep due to pain, shoulder feels pulled on, pt states she cannot raise her arm at all.
Fainted after 2nd dose.  H x of fainting after vaccines.  Hx anxiety
Information has been received from a registered nurse referring to an unspecified number of unspecified patients of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported. On unspecified dates, the patients were vaccinated with an unspecified number of doses of GARDASIL, intramuscularly which were each greater than the prescribed 0.5 ml. The nurse reported this occurred due to the fact that healthcare providers at her facility withdrew administered the entire contents of single-dose vials of all vaccines, and due to expected slight overfill of GARDASIL single-dose vials. The doses that were ultimately administered to the patients could therefore range anywhere from 0.55 ml to 0.6 ml. No adverse effects were reported. No product quality complaint was identified since slight overfill of single-dose vials was expected. This is one of several cases from the same reporter. Additional information has been requested.
Severe muscle pain and aches beginning 7-8 hours after vaccinated, muscle pain/charlie horse feelings all over body, low grade fever, chills, headache, very weak to get up off couch or bed  Tylenol taken every 5 hours - only helped for 2 hours after taken each time  Est. Delivery Date: August 1, 2021
hardness at injection sight.; May 12, 13, 14, 15 bone and muscle aches all over; May 12, 13, 14, 15 bone and muscle aches all over; intermittent fever; no energy; This is a spontaneous report received from a contactable Other HCP (Nurse). This 57-year-old non-pregnant female Nurse (patient herself) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EWD176; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 10May2021 17:00 (at the age of 57-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medication included fluoxetine (FLUOXETINE) taken for an unspecified indication. The patient previously took erythromycin and experienced drug hypersensitivity. On 12May2021 22:00 the patient experienced hardness at injection sight, may 12, 13, 14, 15 bone and muscle aches all over, intermittent fever and no energy. Patient did not receive any treatment for adverse event. The patient underwent lab tests and procedures which included SARS-COV-2 antibody test (Nasal Swab) negative on 14May2021 post the vaccination. The outcome of event hardness at injection sight was resolved on an unspecified date in 2021 while all other events was resolved on 15May2021.  Follow-Up (12Jul2021): Follow-up attempts are completed. No further information is expected.
Patient stated that she's had pain at her injection site since the day she got her 2nd Vaccine. Patient has not visited doctor yet.